Heme-mediated cell activation: the inflammatory puzzle of sickle cell anemia

References

• Ingram VM. A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin. Nature. 1956;178:792–794. Epub 1956/10/13.
   PubMed Web of Science ®Google Scholar
• Pauling L, Itano HA, Singer SJ, et al. Sickle cell anemia, a molecular disease. Science (New York, NY). 1949;110:543–548. Epub 1949/11/2 5.
   Google Scholar
• Steinberg MH. Management of sickle cell disease. N Engl J Med. 1999;340:1021–1030. Epub 1999/04/01.
   PubMed Web of Science ®Google Scholar
• Odievre MH, Verger E, Silva-Pinto AC, et al. Pathophysiological insights in sickle cell disease. Indian J Med Res. 2011;134:532–537. Epub 2011/11/18.
   PubMedGoogle Scholar
• Steinberg MH. Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches. Scientific World J. 2008;8:1295–1324. Epub 2008/12/30.
   Web of Science ®Google Scholar
• Chiang EY, Frenette PS. Sickle cell vaso-occlusion. Hematol Oncol Clin North Am. 2005;19:771–784. v. Epub 2005/10/11.
   PubMed Web of Science ®Google Scholar
• Quinn CT, Smith EP, Arbabi S, et al. Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia. Am J Hematol. 2016;91:1195–1201. Epub 2016/09/21.
   PubMed Web of Science ®Google Scholar
• Kong W-N, Lei Y-H, Chang Y-Z. The regulation of iron metabolism in the mononuclear phagocyte system. Expert Rev Hematol. 2013;6:411–418.
   PubMed Web of Science ®Google Scholar
• Pizzi M, Fuligni F, Santoro L, et al. Spleen histology in children with sickle cell disease and hereditary spherocytosis: hints on the disease pathophysiology. Hum Pathol. 2017;60:95–103. Epub 2016/10/25.
   PubMed Web of Science ®Google Scholar
• Nebor D, Broquere C, Brudey K, et al. Alpha-thalassemia is associated with a decreased occurrence and a delayed age-at-onset of albuminuria in sickle cell anemia patients. Blood Cells Mol Dis. 2010;45:154–158. Epub 2010/07/06.
   PubMed Web of Science ®Google Scholar
• JGt T, Nolan VG, Mendelsohn L, et al. Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain. Plos One. 2008;3:e2095. Epub 2008/05/08.
   PubMed Web of Science ®Google Scholar
• Smith A, McCulloh RJ. Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders. Front Physiol. 2015;6:187. Epub 2015/07/16.
   PubMed Web of Science ®Google Scholar
• Wakefield TW, Myers DD, Henke PK. Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol. 2008;28:387–391. Epub 2008/02/26.
   PubMed Web of Science ®Google Scholar
• Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation. 2004;11:129–151. Epub 2004/07/29.
   PubMed Web of Science ®Google Scholar
• Becker BF, Heindl B, Kupatt C, et al. Endothelial function and hemostasis. Z Kardiol. 2000;89:160–167. Epub 2000/05/08.
   PubMedGoogle Scholar
• Johnson C, Telen MJ. Adhesion molecules and hydroxyurea in the pathophysiology of sickle cell disease. Haematologica. 2008;93:481–485. Epub 2008/04/02.
   PubMed Web of Science ®Google Scholar
• Belcher JD, Chen C, Nguyen J, et al. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood. 2014;123:377–390. Epub 2013/11/28.
   PubMed Web of Science ®Google Scholar
• Setty BN, Betal SG, Zhang J, et al. Heme induces endothelial tissue factor expression: potential role in hemostatic activation in patients with hemolytic anemia. J Thromb Haemost. 2008;6:2202–2209. Epub 2008/11/06.
   PubMed Web of Science ®Google Scholar
• Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21:37–47. Epub 2006/11/07.
   PubMed Web of Science ®Google Scholar
• Nolan VG, Adewoye A, Baldwin C, et al. Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. Br J Haematol. 2006;133:570–578. Epub 2006/05/10.
   PubMed Web of Science ®Google Scholar
• Conran N, Almeida CB, Lanaro C, et al. Inhibition of caspase-dependent spontaneous apoptosis via a cAMP-protein kinase A dependent pathway in neutrophils from sickle cell disease patients. Br J Haematol. 2007;139:148–158. Epub 2007/08/23.
   PubMed Web of Science ®Google Scholar
• Croizat H. Circulating cytokines in sickle cell patients during steady state. Br J Haematol. 1994;87:592–597. Epub 1994/07/01.
   PubMed Web of Science ®Google Scholar
• Francis RB Jr., Haywood LJ. Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease. J Natl Med Assoc. 1992;84:611–615. Epub 1992/07/11.
   PubMed Web of Science ®Google Scholar
• Cerqueira BAV, Boas WV, Zanette AD, et al. Increased concentrations of IL-18 and uric acid in sickle cell anemia: contribution of hemolysis, endothelial activation and the inflammasome. Cytokine. 2011;56:471–476. Epub 2011/08/30.
   PubMed Web of Science ®Google Scholar
• Vilas-Boas W, Veloso Cerqueira BA, Figueiredo CV, et al. Association of homocysteine and inflammatory-related molecules in sickle cell anemia. Hematology. 2016;21:126–131. Epub 2015/09/04.
   PubMed Web of Science ®Google Scholar
• Hebbel RP. Adhesion of sickle red cells to endothelium: myths and future directions. Transfus Clin Biol. 2008;15:14–18. Epub 2008/05/27.
   PubMed Web of Science ®Google Scholar
• Safaya S, Steinberg MH, Klings ES. Monocytes from sickle cell disease patients induce differential pulmonary endothelial gene expression via activation of NF-kappaB signaling pathway. Mol Immunol. 2012;50:117–123. Epub 2012/01/24.
   PubMed Web of Science ®Google Scholar
• Turhan A, Weiss LA, Mohandas N, et al. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proceedings of the National Academy of Sciences of the United States of America. 2002;99:3047–3051. Epub 2002/03/07.
   Google Scholar
• Ataga KI, Kutlar A, Kanter J, et al. Crizanlizumab for the prevention of pain crises in sickle cell disease. N Engl J Med. 2017;376:429–439. Epub 2016/12/14.
   PubMed Web of Science ®Google Scholar
• Joneckis CC, Ackley RL, Orringer EP, et al. Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia. Blood. 1993;82:3548–3555. Epub 1993/12/15.
   PubMed Web of Science ®Google Scholar
• Sugihara K, Sugihara T, Mohandas N, et al. Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. Blood. 1992;80:2634–2642. Epub 1992/11/15.
   PubMed Web of Science ®Google Scholar
• Swerlick RA, Eckman JR, Kumar A, et al. Alpha 4 beta 1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium. Blood. 1993;82:1891–1899. Epub 1993/09/15.
   PubMed Web of Science ®Google Scholar
• Odievre MH, Bony V, Benkerrou M, et al. Modulation of erythroid adhesion receptor expression by hydroxyurea in children with sickle cell disease. Haematologica. 2008;93:502–510. Epub 2008/03/07.
   PubMed Web of Science ®Google Scholar
• Hoppe CC. Inflammatory mediators of endothelial injury in sickle cell disease. Hematol Oncol Clin North Am. 2014;28:265–286. Epub 2014/03/05.
   PubMed Web of Science ®Google Scholar
• Rother RP, Bell L, Hillmen P, et al. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. Jama. 2005;293:1653–1662. Epub 2005/04/07.
   PubMed Web of Science ®Google Scholar
• Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8:1383–1389. Epub 2002/11/12.
   PubMed Web of Science ®Google Scholar
• Rees DC, Gibson JS. Biomarkers in sickle cell disease. Br J Haematol. 2012;156:433–445. Epub 2011/11/30.
   PubMed Web of Science ®Google Scholar
• Camerer E, Kolsto AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res. 1996;81:1–41. Epub 1996/01/01.
   PubMed Web of Science ®Google Scholar
• Mazzolai L, Silacci P, Bouzourene K, et al. Tissue factor activity is upregulated in human endothelial cells exposed to oscillatory shear stress. Thromb Haemost. 2002;87:1062–1068. Epub 2002/06/27.
   PubMed Web of Science ®Google Scholar
• Solovey A, Kollander R, Shet A, et al. Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin. Blood. 2004;104:840–846. Epub 2004/04/10.
   PubMed Web of Science ®Google Scholar
• Feng C, Taiakina V, Ghosh DK, et al. Intraprotein electron transfer between the FMN and heme domains in endothelial nitric oxide synthase holoenzyme. Biochim Biophys Acta. 2011;1814:1997–2002. Epub 2011/08/26.
   PubMed Web of Science ®Google Scholar
• Busse R, Mulsch A. Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Letters. 1990;265:133–136. Epub 1990/06/04.
   PubMed Web of Science ®Google Scholar
• Heller R, Munscher-Paulig F, Grabner R, et al. L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J Biol Chem. 1999;274:8254–8260. Epub 1999/03/13.
   PubMed Web of Science ®Google Scholar
• Dichtl W, Dulak J, Frick M, et al. HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2003;23:58–63. Epub 2003/01/14.
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev. 1998;8:588–594. Epub 1998/10/31.
   PubMed Web of Science ®Google Scholar
• Lok CN, Ponka P. Identification of a hypoxia response element in the transferrin receptor gene. J Biol Chem. 1999;274:24147–24152. Epub 1999/08/14.
   PubMed Web of Science ®Google Scholar
• Tacchini L, Bianchi L, Bernelli-Zazzera A, et al. Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J Biol Chem. 1999;274:24142–24146. Epub 1999/08/14.
   PubMed Web of Science ®Google Scholar
• Lee PJ, Jiang BH, Chin BY, et al. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem. 1997;272:5375–5381. Epub 1997/02/28.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang F. Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities. Protein Cell. 2015;6:88–100. Epub 2014/12/06.
   PubMed Web of Science ®Google Scholar
• Smith A, Morgan WT. Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein. Biochem J. 1979;182:47–54. Epub 1979/07/15.
   PubMed Web of Science ®Google Scholar
• Wagener FA, Abraham NG, Van Kooyk Y, et al. Heme-induced cell adhesion in the pathogenesis of sickle-cell disease and inflammation. Trends Pharmacol Sci. 2001;22:52–54. Epub 2001/02/13.
   PubMed Web of Science ®Google Scholar
• Almeida CB, Favero ME, Pereira-Cunha FG, et al. Alterations in cell maturity and serum survival factors may modulate neutrophil numbers in sickle cell disease. Exp Biol Med (Maywood). 2011;236:1239–1246. Epub 2011/10/15.
   PubMed Web of Science ®Google Scholar
• Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997;337:762–769. Epub 1997/09/11.
   PubMed Web of Science ®Google Scholar
• Belcher JD, Marker PH, Weber JP, et al. Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood. 2000;96:2451–2459. Epub 2000/09/26.
   PubMed Web of Science ®Google Scholar
• Browne P, Shalev O, Hebbel RP. The molecular pathobiology of cell membrane iron: the sickle red cell as a model. Free Radic Biol Med. 1998;24:1040–1048. Epub 1998/06/02.
   PubMed Web of Science ®Google Scholar
• Pohl U, Lamontagne D. Impaired tissue perfusion after inhibition of endothelium-derived nitric oxide. Basic Res Cardiol. 1991;86Suppl 2:97–105. Epub 1991/01/01.
   PubMed Web of Science ®Google Scholar
• Roumenina LT, Rayes J, Lacroix-Desmazes S, et al. Heme: modulator of plasma systems in hemolytic diseases. Trends Mol Med. 2016;22:200–213. Epub 2016/02/16.
   PubMed Web of Science ®Google Scholar
• Kumar S, Bandyopadhyay U. Free heme toxicity and its detoxification systems in human. Toxicol Lett. 2005;157:175–188. Epub 2005/05/27.
   PubMed Web of Science ®Google Scholar
• Belcher JD, Beckman JD, Balla G, et al. Heme degradation and vascular injury. Antioxid Redox Signal. 2010;12:233–248. Epub 2009/08/25.
   PubMed Web of Science ®Google Scholar
• Jeney V, Balla J, Yachie A, et al. Pro-oxidant and cytotoxic effects of circulating heme. Blood. 2002;100:879–887. Epub 2002/07/20.
   PubMed Web of Science ®Google Scholar
• Santiago RP, Guarda CC, Figueiredo CVB, et al. Hemopexin levels in pediatric SS and SC disease patients: biomarker of hemolysis and Inflammation. Blood. 2016;128:3649.
   Web of Science ®Google Scholar
• Wagener FA, Eggert A, Boerman OC, et al. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood. 2001;98:1802–1811. Epub 2001/09/06.
   PubMed Web of Science ®Google Scholar
• Adisa OA, Hu Y, Ghosh S, et al. Association between plasma free haem and incidence of vaso-occlusive episodes and acute chest syndrome in children with sickle cell disease. Br J Haematol. 2013;162:702–705. Epub 2013/06/28.
   PubMed Web of Science ®Google Scholar
• van Beers EJ, Yang Y, Raghavachari N, et al. Iron, inflammation, and early death in adults with sickle cell disease. Circ Res. 2015;116:298–306. Epub 2014/11/08.
   PubMed Web of Science ®Google Scholar
• Korolnek T, Hamza I. Macrophages and iron trafficking at the birth and death of red cells. Blood. 2015;125:2893–2897. Epub 2015/03/18.
   PubMed Web of Science ®Google Scholar
• Chiabrando D, Vinchi F, Fiorito V, et al. Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes. Front Pharmacol. 2014;5:61. Epub 2014/05/02.
   PubMed Web of Science ®Google Scholar
• Dutra FF, Alves LS, Rodrigues D, et al. Hemolysis-induced lethality involves inflammasome activation by heme. Proceedings of the National Academy of Sciences of the United States of America. 2014;111:E4110–8. Epub 2014/09/17.
   Google Scholar
• Aslan M, Ryan TM, Adler B, et al. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:15215–15220. Epub 2001/12/26.
   Google Scholar
• Nur E, Biemond BJ, Otten HM, et al. Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management. Am J Hematol. 2011;86:484–489. Epub 2011/05/06.
   PubMed Web of Science ®Google Scholar
• Figueiredo RT, Fernandez PL, Mourao-Sa DS, et al. Characterization of heme as activator of Toll-like receptor 4. J Biol Chem. 2007;282:20221–20229. Epub 2007/05/16.
   PubMed Web of Science ®Google Scholar
• Graca-Souza AV, Arruda MA, De Freitas MS, et al. Neutrophil activation by heme: implications for inflammatory processes. Blood. 2002;99:4160–4165. Epub 2002/05/16.
   PubMed Web of Science ®Google Scholar
• Wagener FA, Feldman E, de Witte T, et al. Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells. Proc Soc Exp Biol Med. 1997;216:456–463. Epub 1997/12/24.
   PubMed Web of Science ®Google Scholar
• Monteiro AP, Pinheiro CS, Luna-Gomes T, et al. Leukotriene B4 mediates neutrophil migration induced by heme. J Immunol. 2011;186:6562–6567. Epub 2011/05/04.
   PubMed Web of Science ®Google Scholar
• Arruda MA, Rossi AG, de Freitas MS, et al. Heme inhibits human neutrophil apoptosis: involvement of phosphoinositide 3-kinase, MAPK, and NF-kappaB. J Immunol. 2004;173:2023–2030. Epub 2004/07/22.
   PubMed Web of Science ®Google Scholar
• O’Neill LA, Golenbock D, Bowie AG. The history of Toll-like receptors - redefining innate immunity. Nat Reviews Immunol. 2013;13:453–460. Epub 2013/05/18.
   PubMed Web of Science ®Google Scholar
• Fortes GB, Alves LS, De Oliveira R, et al. Heme induces programmed necrosis on macrophages through autocrine TNF and ROS production. Blood. 2012;119:2368–2375. Epub 2012/01/21.
   PubMed Web of Science ®Google Scholar
• Pitanga TN, Oliveira RR, Zanette DL, et al. Sickle red cells as danger signals on proinflammatory gene expression, leukotriene B4 and interleukin-1 beta production in peripheral blood mononuclear cell. Cytokine. 2016;83:75–84. Epub 2016/04/06.
   PubMed Web of Science ®Google Scholar
• da Guarda CC, Santiago RP, Pitanga TN, et al. Heme changes HIF-alpha, eNOS and nitrite production in HUVECs after simvastatin, HU, and ascorbic acid therapies. Microvasc Res. 2016;106:128–136. Epub 2016/04/20.
   PubMed Web of Science ®Google Scholar
• Wang X, Mendelsohn L, Rogers H, et al. Heme-bound iron activates placenta growth factor in erythroid cells via erythroid Kruppel-like factor. Blood. 2014;124:946–954. Epub 2014/06/12.
   PubMed Web of Science ®Google Scholar
• Camus SM, De Moraes JA, Bonnin P, et al. Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease. Blood. 2015;125:3805–3814. Epub 2015/04/02.
   PubMed Web of Science ®Google Scholar
• Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia. N Engl J Med. 1995;332:1317–1322. Epub 1995/05/18.
   PubMed Web of Science ®Google Scholar
• Carvalho MOS, Rocha LC, Reis JHO, et al. Heme concentration as a biomarker of sickle cell disease severity: its role in steady-state and in crisis patients. Blood. 2015;126:975.
   Web of Science ®Google Scholar
• Schaer DJ, Buehler PW, Alayash AI, et al. Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood. 2013;121:1276–1284. Epub 2012/12/25.
   PubMed Web of Science ®Google Scholar
• Vercellotti GM, Zhang P, Nguyen J, et al. Hepatic overexpression of hemopexin inhibits inflammation and vascular stasis in murine models of sickle cell disease. Mol Med. 2016;22. Epub 2016/07/28.
   PubMed Web of Science ®Google Scholar